Dr Michael Meaney, CM, PhD, CQ, FRSC
Co-Director, Ludmer Centre
Douglas Mental Health University Institute
Perry Pavilion, Room E-4139.1
6875, boulevard LaSalle
Montréal, QC H4H 1R3,
Telephone: +1 514 761-6131 ext. 3938
Dr Meaney is a leading researcher and laboratory director at the Douglas Mental Health University Institute, an Adjunct Senior Investigator at the Singapore Institute for Clinical Sciences, a James McGill Professor in the departments of Psychiatry and Neurology & Neurosurgery at McGill University, and the Director of the Program for the Study of Behaviour, Genes & Environment at McGill University.
Area of Research
Dr Meaney’s laboratory focuses on epigenetics, the biological basis by which environmental factors produce an enduring effect on genomic structures and function, and the resulting phenotype variations, including mental illnesses and learning disabilities. These studies focus on epigenetic modifications to the genome that regulate gene activity, altering or switching them ‘on and off’. This work involves both basic science and translational research models, ranging from studies of molecular mechanisms to brain-development and -function in humans. Dr Meaney is also the director of the Maternal Adversity, Vulnerability & Neurodevelopment (MAVAN) project, a Montreal-based longitudinal study of paediatric epigenetics, and a primary investigator in Singapore’s largest birth cohort study, Growing Up in Singapore Towards healthy Outcomes (GUSTO).
Publications & Impact Profile: In 2014, he was awarded the prestigious Klaus J. Jacobs Research Prize for scientific work of high social relevance in child development. He was also elected to the Royal Society of Canada and named a Knight of the National Order of Quebec. A recipient of numerous national and international honours, Dr Meaney ranks among the world’s most cited scientists and has been invited to present his findings at research institutes, government health agencies, and scientific meetings worldwide.